TRIPs and Public Health: The Doha Declaration and Africa

The Doha Declaration on the TRIPs Agreement and Public Health (2001), aimed at improving access to medicines, especially for HIV/AIDS, malaria and tuberculosis in developing and least developed countries, has not yet been used for compulsory licences to import generic medicines or for expanding prod...

Full description

Saved in:
Bibliographic Details
Published in:Development policy review 2007-01, Vol.25 (1), p.71-90
Main Authors: Haakonsson, Stine Jessen, Richey, Lisa Ann
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Disease control
HIV
Human immunodeficiency virus
Human immunodeficiency virus - Uganda
International trade
Pharmaceutical industry - Developing countries
Public health
Public health - Africa
Studies
Trade agreements
World trade organization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Doha Declaration on the TRIPs Agreement and Public Health (2001), aimed at improving access to medicines, especially for HIV/AIDS, malaria and tuberculosis in developing and least developed countries, has not yet been used for compulsory licences to import generic medicines or for expanding production for export to poor countries. By analysing HIV/AIDS treatment in Uganda, this article discusses the variety of TRIPs‐related channels for ensuring drugs for domestic treatment, and argues that emphasising the restrictive nature of TRIPs provisions fails to grasp the scale of the obstacles involved. Lack of domestic resources leaves African countries dependent on donor financing, which in turn constrains their ability to exploit international trade provisions.
ISSN:0950-6764
1467-7679
DOI:10.1111/j.1467-7679.2007.00360.x